detect
low
viru
concentr
biolog
matric
especi
stool
sampl
face
signific
limit
far
common
diagnost
method
enzymelinkedimmunosorb
assay
elisa
quantit
realtim
pcr
qpcr
consid
develop
new
immuno
realtim
pcr
ipcr
describ
perform
detect
human
adenovirus
hadv
spike
stool
compar
elisa
qpcr
assay
ipcr
detect
sandwich
form
complex
captur
antibodyantigendetect
antibodi
perform
qpcr
thank
substitut
peroxydas
chimer
dna
modif
increas
detect
sensit
compar
elisa
direct
qpcr
result
reveal
spike
hadv
detect
result
import
loss
dna
occur
extract
step
step
necessari
ipcr
workflow
avoid
drawback
loss
viral
particl
occur
elut
step
stool
recoveri
rate
ipcr
thu
better
rang
result
ipcr
enabl
detect
lower
viru
concentr
stool
sampl
compar
detect
elisa
qpcr
ipcr
could
consid
hyper
sensit
elisa
earli
detect
hadv
infect
especi
case
immunocompromis
patient
haematopoiet
stem
cell
transplant
human
adenovirus
hadv
nonenvelop
icosahedr
doublestrand
dna
virus
rang
size
nm
diamet
current
describ
human
type
dispatch
type
repres
seven
speci
ag
belong
genu
mastadenoviru
adenovirida
famili
commonli
respons
wide
rang
respiratori
gastrointestin
ophthalm
ill
hadv
type
excret
high
number
faec
infect
peopl
regardless
initi
infect
site
hadv
establish
longlast
indiscern
infect
result
infect
person
shed
virus
unknowingli
serv
sourc
infect
individu
recoveri
ill
hadv
especi
member
hadvc
speci
may
maintain
latent
persist
infect
tonsil
adenoid
lymphoid
tissu
type
eg
continu
present
popul
peopl
thu
expos
primari
infect
least
human
popul
posit
one
hadv
antibodi
even
though
acut
diseas
declar
contrari
hadv
infect
primari
infect
reactiv
latent
virus
immunocompromis
peopl
tend
becom
invas
fatal
rate
may
high
haematopoiet
stem
cell
transplant
immun
system
weaken
mani
virus
identifi
major
risk
patient
hadv
therefor
emerg
lifethreaten
agent
sever
immunocompromis
patient
haematopoiet
stem
cell
recipi
main
method
use
detect
hadv
clinic
sampl
blood
stool
antigen
detect
assay
enzymelinkedimmunosorb
assay
elisa
immunofluoresc
immunochromatographi
test
molecular
biolog
assay
quantit
realtim
pcr
qpcr
immunodetect
method
particular
interest
yield
result
quickli
despit
low
sensit
gener
use
screen
hadv
stool
sampl
respiratori
fluid
infect
children
kind
sampl
heavili
load
hadv
particl
case
infect
qpcr
consid
sensit
robust
fast
techniqu
recent
european
guidelin
diagnosti
treatment
adenoviru
infect
stem
cell
transplant
recommend
qpcr
monitor
hadv
highrisk
patient
previous
suggest
use
tool
interest
screen
hadv
stool
sampl
instead
blood
highlight
hadv
viral
load
stool
sampl
preced
presenc
hadv
blood
qpcr
workflow
requir
preliminari
viral
dna
isol
extract
purif
nucleic
acid
critic
step
molecular
detect
virus
complex
sampl
stool
even
though
extract
kit
well
adapt
use
clinic
set
stage
dna
loss
occur
result
underestim
hadv
concentr
moreov
presenc
potenti
pcr
inhibitor
found
stool
specimen
lipid
polysaccharid
bile
salt
also
perturb
qpcr
reaction
lead
falseneg
result
altern
method
name
immunopcr
develop
last
decad
consid
promis
ultrasensit
diagnost
tool
despit
still
scarc
routin
applic
techniqu
combin
specif
antibodi
amplif
power
sensit
q
pcr
without
nucleic
acid
extract
step
context
aim
studi
develop
optim
immuno
realtim
pcr
ipcr
detect
hadv
particl
stool
sampl
ii
compar
perform
newli
develop
assay
exist
routin
use
method
sandwich
elisa
qpcr
multipl
health
protect
agenc
cultur
collect
ncpv
american
type
cultur
collect
perform
infect
human
embryon
kidney
cell
life
technolog
hall
belgium
previous
describ
concentr
viral
stock
estim
probabl
number
assay
concentr
express
probabl
number
cytopathogen
unit
per
millilitr
mpncuml
stool
sampl
child
infect
hadv
detect
perform
elisa
qpcr
ipcr
use
spike
experi
stool
sampl
spike
within
rang
mg
stool
use
syring
mix
potterelvehjem
homogen
elut
virus
perform
ad
ml
phosphatebuff
salin
pb
mm
nacl
mm
kcl
mm
kh
po
mm
na
hpo
ph
four
glass
bead
stool
dissolv
pb
vortex
h
rpm
room
temperatur
rt
sampl
centrifug
g
min
collect
supernat
use
perform
analysi
use
three
differ
detect
method
antibodi
isotyp
hytest
use
captur
detect
antibodi
respect
detect
antibodi
biotinyl
antibodi
direct
genusspecif
hexon
antigen
target
mastadenoviru
genu
includ
human
adenoviru
type
among
other
specif
antibodi
valid
sandwich
elisa
procedur
use
human
type
belong
four
distinct
human
adenoviru
speci
data
shown
step
fifti
microlitr
captur
antibodi
final
concentr
mgml
coat
buffer
mgl
nahco
mgl
na
co
ph
place
well
polypropylen
pcr
plate
life
technolog
incub
h
nonbind
antibodi
remov
five
wash
pbst
pb
step
one
hundr
fifti
microlitr
casein
solut
pb
place
well
incub
min
follow
five
wash
pbst
step
fifti
microlitr
sampl
dilut
place
well
dilut
perform
casein
incub
rt
h
follow
five
wash
pbst
step
fifti
microlitr
biotinyl
detect
antibodi
final
concentr
mgml
casein
place
well
incub
h
rt
nonbind
antibodi
elimin
three
wash
pbst
three
addit
wash
perform
pb
contain
casein
step
fifti
microlitr
streptavidinconjug
horseradish
peroxidas
hrp
dakodiagnost
final
concentr
dilut
casein
ad
well
incub
min
dark
rt
follow
five
wash
pbst
step
quantif
antigen
indirectli
measur
activ
hrp
fifti
microlitr
tetramethylbenzidin
tm
ultra
tmbelisa
fisher
scientif
tournai
belgium
place
well
incub
dark
min
rt
reaction
stop
addit
h
absorb
read
nm
synergi
multimod
micropl
reader
biotek
bad
friedrichshal
germani
step
previous
describ
sandwich
elisa
step
peroxidas
substitut
end
biotinyl
dna
report
form
streptavidindna
report
complex
quantifi
qpcr
fig
dna
report
design
detect
system
previous
describ
dna
molecul
combin
two
dna
fragment
eukaryot
prokaryot
plasmid
step
fifti
microlitr
streptavidindna
report
complex
dilut
casein
place
well
incub
min
rt
follow
five
wash
wb
ten
wash
dnasernas
free
water
step
dna
report
quantif
perform
use
mesa
green
qpcr
mastermix
plu
low
rox
eurogentec
li
ege
belgium
follow
final
concentr
final
volum
mastermix
lm
forward
revers
primer
fast
realtim
pcr
system
life
technolog
thermal
cycl
condit
initi
min
activ
meteortaq
polymeras
follow
cycl
min
final
dissoci
step
primer
specif
control
presenc
singl
peak
melt
curv
direct
qpcr
dna
extract
viral
stock
use
qiaamp
viral
rna
mini
kit
qiagen
venlo
netherland
supernat
stool
sampl
viral
dna
extract
qiaamp
viral
rna
mini
kit
qiaamp
dna
stool
mini
kit
qiagen
quantif
adenoviru
dna
perform
previous
develop
qpcr
system
use
degener
primer
taqman
probe
upstream
downstream
primer
sequenc
cwt
aca
tgc
aca
tck
csg
crc
ggg
cra
ayt
gca
cca
respect
sequenc
ad
acdef
probe
ggc
tca
ggt
act
ccg
agg
cgt
detect
qpcr
inhibitor
dna
extract
stool
perform
ad
equival
copiesreact
dna
extract
dna
nonspik
stool
sampl
detect
concentr
stool
sampl
c
stool
compar
concentr
obtain
dna
concentr
water
c
pur
dna
potenti
inhibit
express
percentag
calcul
follow
c
stool
c
pur
dna
qpcr
limit
detect
lod
measur
concentr
dna
give
signal
significantli
differ
neg
control
sandwich
elisa
lod
defin
valu
neg
control
two
standard
deviat
limit
cmi
quantif
loq
defin
minimum
valu
linear
dynam
rang
observ
standard
curv
ipcr
lod
defin
lower
concentr
give
differ
c
correspond
sd
compar
given
neg
control
loq
defin
lowest
level
dna
detect
provid
accept
level
precis
ie
replic
amplifi
c
standard
deviat
inferior
mean
c
sensit
perform
sandwich
elisa
realtim
order
defin
lod
loq
dynam
rang
differ
techniqu
rang
concentr
virusesreact
hadv
type
suspens
steril
milliq
water
analys
elisa
qpcr
ipcr
result
shown
tabl
standard
curv
obtain
use
ipcr
assay
present
fig
qpcr
analysi
recoveri
rate
rang
fig
seem
proport
viral
concentr
ie
recoveri
rate
decreas
ad
concentr
decreas
due
low
recoveri
rate
estim
lowest
detect
viru
concentr
stool
sampl
particl
per
gram
stool
tabl
similar
result
obtain
use
qiaamp
dna
stool
kit
qiagen
dna
extract
yield
detect
rang
use
sandwich
elisa
loss
viral
signal
less
import
one
occur
qpcr
assay
consid
valu
threshold
neg
lower
detect
concentr
mpncureact
correspond
ad
concentr
mpncureact
lower
posit
concentr
mpncureact
correspond
ad
concentr
mpncu
reaction
fig
thu
recoveri
rate
rang
fig
loq
mpncureact
consid
restrict
factor
consequ
lowest
detect
viru
concentr
superior
particl
per
gram
stool
tabl
use
ipcr
recoveri
rate
rang
fig
better
detect
observ
yield
rang
recoveri
rate
rang
addit
better
detect
limit
ipcr
allow
quantif
lower
concentr
hadv
stool
sampl
detect
direct
qpcr
thu
use
ipcr
posit
result
obtain
viru
concentr
superior
equal
particl
per
gram
stool
sampl
tabl
today
qpcrbase
assay
establish
standard
diagnost
tool
detect
hadv
clinic
materi
immunocompromis
patient
due
technic
benefit
high
sensit
specif
rapid
quantit
detect
studi
new
diagnost
tool
base
combin
immunodetect
success
qpcr
propos
detect
hadv
especi
stool
sampl
detect
known
often
tricki
use
ipcr
assay
alreadi
demonstr
sever
viral
antigen
eg
norovirus
rotavirus
detect
low
concentr
stool
sampl
limit
detect
mpncu
genom
copiesreact
limit
quantif
mpncu
genom
copiesreact
dynam
rang
mpncu
genom
copiesreact
lowest
detect
concentr
stool
mpncu
genom
copiesg
stool
detect
immunodetect
tool
viral
particl
must
releas
beforehand
stool
sampl
elut
step
transfer
virus
aqueou
phase
mechan
dispers
stool
pb
major
caus
viru
loss
also
order
reduc
concentr
interf
compon
within
eluat
stool
sampl
clarifi
centrifug
analysi
howev
complex
matric
stool
larg
concentr
interf
compon
could
persist
eluat
even
preliminari
clarif
step
lead
impact
recoveri
rate
observ
present
studi
ipcr
procedur
develop
display
lod
purifi
viral
particl
per
reaction
indic
sensit
higher
sandwich
elisa
assay
purifi
viral
particl
find
consist
previou
report
ipcr
describ
sensit
improv
compar
elisa
stool
sampl
ipcr
sandwich
elisa
exhibit
similar
recoveri
rate
consid
high
easili
explain
ident
first
step
antigenantibodi
detect
methodolog
approach
unrecov
virus
either
sequest
stool
detect
due
interfer
occur
immunodetect
stage
compound
lipid
protein
known
hinder
antigenantibodi
reaction
modifi
andor
neutral
fixat
site
antigen
andor
antibodi
drawback
ipcr
high
background
nois
mainli
due
nonspecif
bind
chimer
dna
wall
well
avoid
phenomenon
chimer
dna
could
coupl
detect
antibodi
addit
well
background
nois
may
thu
reduc
result
improv
detect
sensit
accord
result
ipcr
sensit
compar
qpcr
use
purifi
viral
suspens
howev
ipcr
requir
dna
extract
purif
step
asset
analysi
complex
clinic
sampl
stool
result
show
maximum
spike
hadv
stool
sampl
detect
use
direct
qpcr
detect
rate
ipcr
reach
import
dna
loss
occur
nucleic
acid
extract
step
certainli
explain
find
studi
show
spike
stool
sampl
detect
qpcr
regardless
extract
kit
use
result
latter
studi
highlight
consider
loss
dna
equal
higher
log
use
three
differ
extract
kit
includ
qiaamp
viral
rna
mini
kit
amplif
reaction
also
hinder
interf
compon
two
studi
extract
detect
coronavirus
stool
demonstr
pcr
inhibitor
present
nucleic
acid
extract
could
interfer
perform
qpcr
present
work
low
pcr
inhibit
observ
indic
poor
hadv
detect
use
qpcr
princip
due
low
dna
extract
effici
conclus
two
major
drawback
qpcr
loss
viral
dna
occur
extract
step
pcr
inhibit
use
analysi
stool
sampl
avoid
use
ipcr
inde
numer
wash
step
occur
ipcr
workflow
allow
elimin
larg
part
qpcr
inhibitor
viral
dna
purif
step
need
develop
techniqu
power
allow
detect
small
amount
hadv
particl
stool
sampl
knowledg
first
descript
ipcr
hadv
improv
abil
decreas
detect
limit
hadv
complex
biolog
matric
thu
avoid
underestim
viral
concentr
abil
particularli
interest
earli
detect
hadv
immunocompromis
patient
earli
detect
hadv
stool
allow
rapid
implement
treatment
use
antivir
adopt
immunotherapi
prevent
dissemin
infect
hadv
